BlackRock
KLDO

BlackRock’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

BlackRock’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-913,506
Closed -$1.51M – 6110
2022
Q1 		$1.51M Sell
913,506
-10,325
-1% -$18.4K ﹤0.01% 4508
2021
Q4 		$2.21M Sell
923,831
-172,997
-16% -$704K ﹤0.01% 4367
2021
Q3 		$5.99M Buy
1,096,828
+21,806
+2% +$135K ﹤0.01% 3883
2021
Q2 		$8M Buy
1,075,022
+64,659
+6% +$458K ﹤0.01% 3722
2021
Q1 		$8.18M Buy
1,010,363
+71,732
+8% +$781K ﹤0.01% 3689
2020
Q4 		$8.54M Buy
938,631
+404,988
+76% +$3.32M ﹤0.01% 3449
2020
Q3 		$5.91M Sell
533,643
-1,297
-0.2% -$8.98K ﹤0.01% 3498
2020
Q2 		$3.98M Sell
534,940
-25,651
-5% -$172K ﹤0.01% 3612
2020
Q1 		$3.45M Buy
560,591
+51,840
+10% +$338K ﹤0.01% 3483
2019
Q4 		$2.55M Buy
508,751
+255,824
+101% +$1.63M ﹤0.01% 3711
2019
Q3 		$1.9M Buy
252,927
+8,555
+4% +$74.3K ﹤0.01% 3770
2019
Q2 		$2.83M Buy
+244,372
New +$3.56M ﹤0.01% 3668

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock's KLDO Position: Q2 2022 in Review

BlackRock sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 913,506 shares — an estimated $1.51M sold.

BlackRock first reported a position in KLDO in Q2 2019 and held it in 12 quarters. The position peaked at $8.54M in Q4 2020. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • BlackRock reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • BlackRock sold 913,506 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $1.51M.
  • BlackRock first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • BlackRock's Kaleido Biosciences, Inc. Common Stock position peaked at $8.54M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.